nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—hematologic cancer	0.0943	1	CbGaD
Rosiglitazone—CYP2A6—Methoxsalen—hematologic cancer	0.0291	0.05	CbGbCtD
Rosiglitazone—CYP1A2—Anagrelide—hematologic cancer	0.0249	0.0427	CbGbCtD
Rosiglitazone—PTGS1—Bortezomib—hematologic cancer	0.0236	0.0406	CbGbCtD
Rosiglitazone—CYP2A6—Ifosfamide—hematologic cancer	0.0212	0.0364	CbGbCtD
Rosiglitazone—PTGS1—Thalidomide—hematologic cancer	0.0206	0.0354	CbGbCtD
Rosiglitazone—PTGS1—Ifosfamide—hematologic cancer	0.0181	0.0311	CbGbCtD
Rosiglitazone—PTGS1—Imatinib—hematologic cancer	0.0173	0.0297	CbGbCtD
Rosiglitazone—CYP2C9—Bexarotene—hematologic cancer	0.0155	0.0267	CbGbCtD
Rosiglitazone—SLCO1B1—Irinotecan—hematologic cancer	0.0148	0.0253	CbGbCtD
Rosiglitazone—CYP2A6—Prednisolone—hematologic cancer	0.0141	0.0243	CbGbCtD
Rosiglitazone—CYP2C8—Bortezomib—hematologic cancer	0.0136	0.0234	CbGbCtD
Rosiglitazone—CYP2D6—Lomustine—hematologic cancer	0.0132	0.0227	CbGbCtD
Rosiglitazone—CYP1A2—Carmustine—hematologic cancer	0.0131	0.0224	CbGbCtD
Rosiglitazone—ALB—Imatinib—hematologic cancer	0.0129	0.0222	CbGbCtD
Rosiglitazone—CYP2C9—Idarubicin—hematologic cancer	0.0129	0.0221	CbGbCtD
Rosiglitazone—CYP2D6—Idarubicin—hematologic cancer	0.0118	0.0202	CbGbCtD
Rosiglitazone—CYP2C19—Bortezomib—hematologic cancer	0.0114	0.0197	CbGbCtD
Rosiglitazone—CYP1A2—Methoxsalen—hematologic cancer	0.0111	0.0191	CbGbCtD
Rosiglitazone—CYP1A2—Bortezomib—hematologic cancer	0.0106	0.0181	CbGbCtD
Rosiglitazone—CYP2C8—Ifosfamide—hematologic cancer	0.0105	0.018	CbGbCtD
Rosiglitazone—CYP1A2—Daunorubicin—hematologic cancer	0.0101	0.0173	CbGbCtD
Rosiglitazone—CYP2D6—Hydroxyurea—hematologic cancer	0.01	0.0172	CbGbCtD
Rosiglitazone—CYP2C19—Thalidomide—hematologic cancer	0.00997	0.0171	CbGbCtD
Rosiglitazone—CYP1A2—Alitretinoin—hematologic cancer	0.0099	0.017	CbGbCtD
Rosiglitazone—CYP2C9—Bortezomib—hematologic cancer	0.00952	0.0163	CbGbCtD
Rosiglitazone—CYP2C19—Teniposide—hematologic cancer	0.00951	0.0163	CbGbCtD
Rosiglitazone—CYP1A2—Thalidomide—hematologic cancer	0.0092	0.0158	CbGbCtD
Rosiglitazone—CYP2C8—Nilotinib—hematologic cancer	0.00908	0.0156	CbGbCtD
Rosiglitazone—CYP2C19—Ifosfamide—hematologic cancer	0.00878	0.0151	CbGbCtD
Rosiglitazone—CYP2D6—Bortezomib—hematologic cancer	0.0087	0.0149	CbGbCtD
Rosiglitazone—PTGS1—Etoposide—hematologic cancer	0.00867	0.0149	CbGbCtD
Rosiglitazone—ALB—Prednisone—hematologic cancer	0.00852	0.0146	CbGbCtD
Rosiglitazone—CYP2C19—Imatinib—hematologic cancer	0.00839	0.0144	CbGbCtD
Rosiglitazone—CYP2A6—Dexamethasone—hematologic cancer	0.00834	0.0143	CbGbCtD
Rosiglitazone—CYP2C9—Thalidomide—hematologic cancer	0.00829	0.0142	CbGbCtD
Rosiglitazone—ALB—Irinotecan—hematologic cancer	0.00808	0.0139	CbGbCtD
Rosiglitazone—CYP1A2—Dacarbazine—hematologic cancer	0.00791	0.0136	CbGbCtD
Rosiglitazone—CYP2C9—Teniposide—hematologic cancer	0.00791	0.0136	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—hematologic cancer	0.00781	0.0134	CbGbCtD
Rosiglitazone—CYP1A2—Imatinib—hematologic cancer	0.00774	0.0133	CbGbCtD
Rosiglitazone—CYP2C9—Ifosfamide—hematologic cancer	0.0073	0.0125	CbGbCtD
Rosiglitazone—CYP2C9—Imatinib—hematologic cancer	0.00697	0.012	CbGbCtD
Rosiglitazone—CYP2D6—Imatinib—hematologic cancer	0.00638	0.0109	CbGbCtD
Rosiglitazone—CYP2C9—Nilotinib—hematologic cancer	0.00634	0.0109	CbGbCtD
Rosiglitazone—CYP1A2—Dasatinib—hematologic cancer	0.00622	0.0107	CbGbCtD
Rosiglitazone—CYP2D6—Nilotinib—hematologic cancer	0.00579	0.00995	CbGbCtD
Rosiglitazone—CYP2D6—Vinorelbine—hematologic cancer	0.00575	0.00987	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—hematologic cancer	0.00553	0.00949	CbGbCtD
Rosiglitazone—CYP2C8—Etoposide—hematologic cancer	0.005	0.00859	CbGbCtD
Rosiglitazone—ALB—Methotrexate—hematologic cancer	0.00428	0.00734	CbGbCtD
Rosiglitazone—CYP2C8—Dexamethasone—hematologic cancer	0.00411	0.00706	CbGbCtD
Rosiglitazone—CYP1A2—Etoposide—hematologic cancer	0.00387	0.00665	CbGbCtD
Rosiglitazone—CYP2C9—Cisplatin—hematologic cancer	0.00355	0.0061	CbGbCtD
Rosiglitazone—CYP2D6—Vinblastine—hematologic cancer	0.00354	0.00608	CbGbCtD
Rosiglitazone—CYP2C19—Dexamethasone—hematologic cancer	0.00345	0.00592	CbGbCtD
Rosiglitazone—CYP2C9—Dexamethasone—hematologic cancer	0.00287	0.00492	CbGbCtD
Rosiglitazone—ACSL4—hematopoietic system—hematologic cancer	0.0028	0.088	CbGeAlD
Rosiglitazone—CYP2D6—Dexamethasone—hematologic cancer	0.00262	0.0045	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—hematologic cancer	0.00218	0.00374	CbGbCtD
Rosiglitazone—ACSL4—gonad—hematologic cancer	0.00213	0.0669	CbGeAlD
Rosiglitazone—ACSL4—blood—hematologic cancer	0.00186	0.0583	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—hematologic cancer	0.0018	0.0564	CbGeAlD
Rosiglitazone—ACSL4—lung—hematologic cancer	0.00163	0.0511	CbGeAlD
Rosiglitazone—ACSL4—testis—hematologic cancer	0.00154	0.0482	CbGeAlD
Rosiglitazone—SLCO1B1—hematopoietic system—hematologic cancer	0.00146	0.0459	CbGeAlD
Rosiglitazone—PPARG—hematopoietic system—hematologic cancer	0.00126	0.0396	CbGeAlD
Rosiglitazone—ACSL4—lymph node—hematologic cancer	0.00111	0.0349	CbGeAlD
Rosiglitazone—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.00101	0.285	CbGdCrCtD
Rosiglitazone—SLCO1B1—blood—hematologic cancer	0.000969	0.0304	CbGeAlD
Rosiglitazone—CYP2C19—hematopoietic system—hematologic cancer	0.000953	0.0299	CbGeAlD
Rosiglitazone—CYP2A6—lung—hematologic cancer	0.00086	0.027	CbGeAlD
Rosiglitazone—PPARG—blood—hematologic cancer	0.000836	0.0262	CbGeAlD
Rosiglitazone—CYP2C8—hematopoietic system—hematologic cancer	0.000832	0.0261	CbGeAlD
Rosiglitazone—PPARG—bone marrow—hematologic cancer	0.000809	0.0254	CbGeAlD
Rosiglitazone—CYP1A2—hematopoietic system—hematologic cancer	0.000778	0.0244	CbGeAlD
Rosiglitazone—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000764	0.216	CbGdCrCtD
Rosiglitazone—CYP2C9—hematopoietic system—hematologic cancer	0.000739	0.0232	CbGeAlD
Rosiglitazone—PPARG—lung—hematologic cancer	0.000733	0.023	CbGeAlD
Rosiglitazone—PPARG—Topotecan—Irinotecan—hematologic cancer	0.000724	0.204	CbGdCrCtD
Rosiglitazone—PPARG—Etoposide—Teniposide—hematologic cancer	0.00072	0.203	CbGdCrCtD
Rosiglitazone—PPARG—testis—hematologic cancer	0.000691	0.0217	CbGeAlD
Rosiglitazone—PTGS1—hematopoietic system—hematologic cancer	0.000674	0.0212	CbGeAlD
Rosiglitazone—ALB—testis—hematologic cancer	0.000648	0.0203	CbGeAlD
Rosiglitazone—CYP2C19—blood—hematologic cancer	0.000631	0.0198	CbGeAlD
Rosiglitazone—CYP2D6—hematopoietic system—hematologic cancer	0.000554	0.0174	CbGeAlD
Rosiglitazone—CYP2C8—blood—hematologic cancer	0.000551	0.0173	CbGeAlD
Rosiglitazone—CYP1A2—blood—hematologic cancer	0.000516	0.0162	CbGeAlD
Rosiglitazone—PPARG—lymph node—hematologic cancer	0.000501	0.0157	CbGeAlD
Rosiglitazone—CYP2C9—blood—hematologic cancer	0.000489	0.0154	CbGeAlD
Rosiglitazone—ALB—lymph node—hematologic cancer	0.00047	0.0147	CbGeAlD
Rosiglitazone—CYP2C8—testis—hematologic cancer	0.000456	0.0143	CbGeAlD
Rosiglitazone—CYP1A2—lung—hematologic cancer	0.000452	0.0142	CbGeAlD
Rosiglitazone—PTGS1—blood—hematologic cancer	0.000447	0.014	CbGeAlD
Rosiglitazone—PTGS1—lung—hematologic cancer	0.000392	0.0123	CbGeAlD
Rosiglitazone—PTGS1—testis—hematologic cancer	0.00037	0.0116	CbGeAlD
Rosiglitazone—CYP2D6—blood—hematologic cancer	0.000367	0.0115	CbGeAlD
Rosiglitazone—PPARG—Teniposide—Etoposide—hematologic cancer	0.000327	0.0921	CbGdCrCtD
Rosiglitazone—CYP2D6—testis—hematologic cancer	0.000304	0.00953	CbGeAlD
Rosiglitazone—PTGS1—lymph node—hematologic cancer	0.000268	0.0084	CbGeAlD
Rosiglitazone—Hyperglycaemia—Epirubicin—hematologic cancer	5.64e-05	0.00028	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—hematologic cancer	5.64e-05	0.00028	CcSEcCtD
Rosiglitazone—Nausea—Bortezomib—hematologic cancer	5.63e-05	0.000279	CcSEcCtD
Rosiglitazone—Asthenia—Vincristine—hematologic cancer	5.62e-05	0.000279	CcSEcCtD
Rosiglitazone—Diarrhoea—Carmustine—hematologic cancer	5.61e-05	0.000279	CcSEcCtD
Rosiglitazone—Nausea—Bleomycin—hematologic cancer	5.58e-05	0.000277	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—hematologic cancer	5.57e-05	0.000277	CcSEcCtD
Rosiglitazone—Rash—Thiotepa—hematologic cancer	5.57e-05	0.000276	CcSEcCtD
Rosiglitazone—Dermatitis—Thiotepa—hematologic cancer	5.56e-05	0.000276	CcSEcCtD
Rosiglitazone—Diarrhoea—Alitretinoin—hematologic cancer	5.56e-05	0.000276	CcSEcCtD
Rosiglitazone—Headache—Thiotepa—hematologic cancer	5.53e-05	0.000275	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	5.53e-05	0.000274	CcSEcCtD
Rosiglitazone—Hypertension—Dexamethasone—hematologic cancer	5.52e-05	0.000274	CcSEcCtD
Rosiglitazone—Hypertension—Betamethasone—hematologic cancer	5.52e-05	0.000274	CcSEcCtD
Rosiglitazone—Diarrhoea—Ifosfamide—hematologic cancer	5.5e-05	0.000273	CcSEcCtD
Rosiglitazone—Nausea—Vinorelbine—hematologic cancer	5.49e-05	0.000273	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Etoposide—hematologic cancer	5.48e-05	0.000272	CcSEcCtD
Rosiglitazone—Asthenia—Mitoxantrone—hematologic cancer	5.47e-05	0.000272	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—hematologic cancer	5.47e-05	0.000272	CcSEcCtD
Rosiglitazone—Fatigue—Etoposide—hematologic cancer	5.47e-05	0.000271	CcSEcCtD
Rosiglitazone—Myalgia—Dexamethasone—hematologic cancer	5.45e-05	0.00027	CcSEcCtD
Rosiglitazone—Myalgia—Betamethasone—hematologic cancer	5.45e-05	0.00027	CcSEcCtD
Rosiglitazone—Dizziness—Carmustine—hematologic cancer	5.43e-05	0.000269	CcSEcCtD
Rosiglitazone—Constipation—Etoposide—hematologic cancer	5.43e-05	0.000269	CcSEcCtD
Rosiglitazone—Rash—Thalidomide—hematologic cancer	5.39e-05	0.000267	CcSEcCtD
Rosiglitazone—Dermatitis—Thalidomide—hematologic cancer	5.38e-05	0.000267	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—hematologic cancer	5.38e-05	0.000267	CcSEcCtD
Rosiglitazone—Dizziness—Alitretinoin—hematologic cancer	5.38e-05	0.000267	CcSEcCtD
Rosiglitazone—Diarrhoea—Vincristine—hematologic cancer	5.36e-05	0.000266	CcSEcCtD
Rosiglitazone—Headache—Thalidomide—hematologic cancer	5.35e-05	0.000266	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—hematologic cancer	5.35e-05	0.000265	CcSEcCtD
Rosiglitazone—Asthenia—Gemcitabine—hematologic cancer	5.33e-05	0.000265	CcSEcCtD
Rosiglitazone—Dizziness—Ifosfamide—hematologic cancer	5.31e-05	0.000264	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—hematologic cancer	5.27e-05	0.000262	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—hematologic cancer	5.27e-05	0.000261	CcSEcCtD
Rosiglitazone—Pruritus—Gemcitabine—hematologic cancer	5.26e-05	0.000261	CcSEcCtD
Rosiglitazone—Nausea—Thiotepa—hematologic cancer	5.25e-05	0.00026	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.24e-05	0.00026	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—hematologic cancer	5.23e-05	0.00026	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Betamethasone—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Oedema—Betamethasone—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Oedema—Dexamethasone—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Dexamethasone—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Diarrhoea—Mitoxantrone—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—hematologic cancer	5.22e-05	0.000259	CcSEcCtD
Rosiglitazone—Infection—Betamethasone—hematologic cancer	5.19e-05	0.000257	CcSEcCtD
Rosiglitazone—Infection—Dexamethasone—hematologic cancer	5.19e-05	0.000257	CcSEcCtD
Rosiglitazone—Dizziness—Vincristine—hematologic cancer	5.18e-05	0.000257	CcSEcCtD
Rosiglitazone—Rash—Carmustine—hematologic cancer	5.17e-05	0.000257	CcSEcCtD
Rosiglitazone—Dermatitis—Carmustine—hematologic cancer	5.17e-05	0.000257	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—hematologic cancer	5.15e-05	0.000256	CcSEcCtD
Rosiglitazone—Headache—Carmustine—hematologic cancer	5.14e-05	0.000255	CcSEcCtD
Rosiglitazone—Rash—Alitretinoin—hematologic cancer	5.13e-05	0.000254	CcSEcCtD
Rosiglitazone—Nervous system disorder—Betamethasone—hematologic cancer	5.12e-05	0.000254	CcSEcCtD
Rosiglitazone—Nervous system disorder—Dexamethasone—hematologic cancer	5.12e-05	0.000254	CcSEcCtD
Rosiglitazone—Dermatitis—Alitretinoin—hematologic cancer	5.12e-05	0.000254	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.12e-05	0.000254	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dexamethasone—hematologic cancer	5.11e-05	0.000254	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Betamethasone—hematologic cancer	5.11e-05	0.000254	CcSEcCtD
Rosiglitazone—Headache—Alitretinoin—hematologic cancer	5.09e-05	0.000253	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—hematologic cancer	5.09e-05	0.000253	CcSEcCtD
Rosiglitazone—Diarrhoea—Gemcitabine—hematologic cancer	5.08e-05	0.000252	CcSEcCtD
Rosiglitazone—Nausea—Thalidomide—hematologic cancer	5.07e-05	0.000252	CcSEcCtD
Rosiglitazone—Rash—Ifosfamide—hematologic cancer	5.07e-05	0.000251	CcSEcCtD
Rosiglitazone—Dermatitis—Ifosfamide—hematologic cancer	5.06e-05	0.000251	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—hematologic cancer	5.06e-05	0.000251	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—hematologic cancer	5.04e-05	0.00025	CcSEcCtD
Rosiglitazone—Urticaria—Etoposide—hematologic cancer	5.04e-05	0.00025	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—hematologic cancer	5.01e-05	0.000248	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—hematologic cancer	5e-05	0.000248	CcSEcCtD
Rosiglitazone—Urticaria—Prednisolone—hematologic cancer	4.97e-05	0.000247	CcSEcCtD
Rosiglitazone—Asthenia—Cisplatin—hematologic cancer	4.97e-05	0.000247	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—hematologic cancer	4.96e-05	0.000246	CcSEcCtD
Rosiglitazone—Fatigue—Triamcinolone—hematologic cancer	4.96e-05	0.000246	CcSEcCtD
Rosiglitazone—Rash—Vincristine—hematologic cancer	4.94e-05	0.000245	CcSEcCtD
Rosiglitazone—Dermatitis—Vincristine—hematologic cancer	4.93e-05	0.000245	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—hematologic cancer	4.93e-05	0.000245	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—hematologic cancer	4.92e-05	0.000244	CcSEcCtD
Rosiglitazone—Headache—Vincristine—hematologic cancer	4.91e-05	0.000244	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—hematologic cancer	4.88e-05	0.000242	CcSEcCtD
Rosiglitazone—Nausea—Carmustine—hematologic cancer	4.87e-05	0.000242	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—hematologic cancer	4.84e-05	0.00024	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—hematologic cancer	4.83e-05	0.00024	CcSEcCtD
Rosiglitazone—Nausea—Alitretinoin—hematologic cancer	4.83e-05	0.00024	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—hematologic cancer	4.81e-05	0.000239	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—hematologic cancer	4.81e-05	0.000239	CcSEcCtD
Rosiglitazone—Rash—Mitoxantrone—hematologic cancer	4.81e-05	0.000239	CcSEcCtD
Rosiglitazone—Dermatitis—Mitoxantrone—hematologic cancer	4.81e-05	0.000238	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—hematologic cancer	4.81e-05	0.000238	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—hematologic cancer	4.78e-05	0.000237	CcSEcCtD
Rosiglitazone—Headache—Mitoxantrone—hematologic cancer	4.78e-05	0.000237	CcSEcCtD
Rosiglitazone—Nausea—Ifosfamide—hematologic cancer	4.77e-05	0.000237	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.76e-05	0.000236	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.76e-05	0.000236	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—hematologic cancer	4.74e-05	0.000235	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—hematologic cancer	4.74e-05	0.000235	CcSEcCtD
Rosiglitazone—Diarrhoea—Cisplatin—hematologic cancer	4.74e-05	0.000235	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—hematologic cancer	4.73e-05	0.000235	CcSEcCtD
Rosiglitazone—Rash—Gemcitabine—hematologic cancer	4.69e-05	0.000233	CcSEcCtD
Rosiglitazone—Dermatitis—Gemcitabine—hematologic cancer	4.68e-05	0.000232	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—hematologic cancer	4.68e-05	0.000232	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Rosiglitazone—Headache—Gemcitabine—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Rosiglitazone—Nausea—Vincristine—hematologic cancer	4.65e-05	0.000231	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—hematologic cancer	4.65e-05	0.000231	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—hematologic cancer	4.63e-05	0.00023	CcSEcCtD
Rosiglitazone—Urticaria—Triamcinolone—hematologic cancer	4.57e-05	0.000227	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—hematologic cancer	4.56e-05	0.000226	CcSEcCtD
Rosiglitazone—Asthenia—Etoposide—hematologic cancer	4.55e-05	0.000226	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—hematologic cancer	4.55e-05	0.000226	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—hematologic cancer	4.55e-05	0.000226	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—hematologic cancer	4.55e-05	0.000226	CcSEcCtD
Rosiglitazone—Nausea—Mitoxantrone—hematologic cancer	4.53e-05	0.000225	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—hematologic cancer	4.53e-05	0.000225	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—hematologic cancer	4.52e-05	0.000224	CcSEcCtD
Rosiglitazone—Infection—Prednisone—hematologic cancer	4.52e-05	0.000224	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.51e-05	0.000224	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.51e-05	0.000224	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—hematologic cancer	4.5e-05	0.000224	CcSEcCtD
Rosiglitazone—Fatigue—Betamethasone—hematologic cancer	4.5e-05	0.000223	CcSEcCtD
Rosiglitazone—Fatigue—Dexamethasone—hematologic cancer	4.5e-05	0.000223	CcSEcCtD
Rosiglitazone—Pruritus—Etoposide—hematologic cancer	4.49e-05	0.000223	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—hematologic cancer	4.46e-05	0.000221	CcSEcCtD
Rosiglitazone—Nausea—Gemcitabine—hematologic cancer	4.41e-05	0.000219	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—hematologic cancer	4.38e-05	0.000217	CcSEcCtD
Rosiglitazone—Rash—Cisplatin—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Rosiglitazone—Dermatitis—Cisplatin—hematologic cancer	4.36e-05	0.000217	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—hematologic cancer	4.36e-05	0.000216	CcSEcCtD
Rosiglitazone—Diarrhoea—Etoposide—hematologic cancer	4.34e-05	0.000215	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—hematologic cancer	4.33e-05	0.000215	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—hematologic cancer	4.3e-05	0.000214	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—hematologic cancer	4.3e-05	0.000213	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—hematologic cancer	4.22e-05	0.000209	CcSEcCtD
Rosiglitazone—Dizziness—Etoposide—hematologic cancer	4.2e-05	0.000208	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—hematologic cancer	4.18e-05	0.000208	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—hematologic cancer	4.17e-05	0.000207	CcSEcCtD
Rosiglitazone—Urticaria—Betamethasone—hematologic cancer	4.15e-05	0.000206	CcSEcCtD
Rosiglitazone—Urticaria—Dexamethasone—hematologic cancer	4.15e-05	0.000206	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.14e-05	0.000206	CcSEcCtD
Rosiglitazone—Dizziness—Prednisolone—hematologic cancer	4.14e-05	0.000205	CcSEcCtD
Rosiglitazone—Asthenia—Triamcinolone—hematologic cancer	4.13e-05	0.000205	CcSEcCtD
Rosiglitazone—Nausea—Cisplatin—hematologic cancer	4.11e-05	0.000204	CcSEcCtD
Rosiglitazone—Pruritus—Triamcinolone—hematologic cancer	4.07e-05	0.000202	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—hematologic cancer	4.03e-05	0.0002	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—hematologic cancer	4.03e-05	0.0002	CcSEcCtD
Rosiglitazone—Rash—Etoposide—hematologic cancer	4e-05	0.000199	CcSEcCtD
Rosiglitazone—Dermatitis—Etoposide—hematologic cancer	4e-05	0.000198	CcSEcCtD
Rosiglitazone—Headache—Etoposide—hematologic cancer	3.98e-05	0.000197	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—hematologic cancer	3.96e-05	0.000197	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—hematologic cancer	3.96e-05	0.000197	CcSEcCtD
Rosiglitazone—Rash—Prednisolone—hematologic cancer	3.95e-05	0.000196	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisolone—hematologic cancer	3.94e-05	0.000196	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—hematologic cancer	3.92e-05	0.000195	CcSEcCtD
Rosiglitazone—Headache—Prednisolone—hematologic cancer	3.92e-05	0.000195	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—hematologic cancer	3.9e-05	0.000194	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—hematologic cancer	3.9e-05	0.000194	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—hematologic cancer	3.89e-05	0.000193	CcSEcCtD
Rosiglitazone—Dizziness—Triamcinolone—hematologic cancer	3.81e-05	0.000189	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—hematologic cancer	3.8e-05	0.000189	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—hematologic cancer	3.78e-05	0.000187	CcSEcCtD
Rosiglitazone—Nausea—Etoposide—hematologic cancer	3.77e-05	0.000187	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—hematologic cancer	3.76e-05	0.000187	CcSEcCtD
Rosiglitazone—Asthenia—Dexamethasone—hematologic cancer	3.75e-05	0.000186	CcSEcCtD
Rosiglitazone—Asthenia—Betamethasone—hematologic cancer	3.75e-05	0.000186	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—hematologic cancer	3.73e-05	0.000185	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—hematologic cancer	3.73e-05	0.000185	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—hematologic cancer	3.72e-05	0.000185	CcSEcCtD
Rosiglitazone—Nausea—Prednisolone—hematologic cancer	3.72e-05	0.000184	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—hematologic cancer	3.71e-05	0.000184	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—hematologic cancer	3.71e-05	0.000184	CcSEcCtD
Rosiglitazone—Pruritus—Dexamethasone—hematologic cancer	3.69e-05	0.000183	CcSEcCtD
Rosiglitazone—Pruritus—Betamethasone—hematologic cancer	3.69e-05	0.000183	CcSEcCtD
Rosiglitazone—Rash—Triamcinolone—hematologic cancer	3.63e-05	0.00018	CcSEcCtD
Rosiglitazone—Dermatitis—Triamcinolone—hematologic cancer	3.63e-05	0.00018	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—hematologic cancer	3.61e-05	0.000179	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—hematologic cancer	3.61e-05	0.000179	CcSEcCtD
Rosiglitazone—Headache—Triamcinolone—hematologic cancer	3.61e-05	0.000179	CcSEcCtD
Rosiglitazone—Diarrhoea—Dexamethasone—hematologic cancer	3.57e-05	0.000177	CcSEcCtD
Rosiglitazone—Diarrhoea—Betamethasone—hematologic cancer	3.57e-05	0.000177	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—hematologic cancer	3.56e-05	0.000177	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—hematologic cancer	3.56e-05	0.000177	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—hematologic cancer	3.53e-05	0.000175	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—hematologic cancer	3.49e-05	0.000173	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—hematologic cancer	3.48e-05	0.000173	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—hematologic cancer	3.48e-05	0.000173	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.46e-05	0.000172	CcSEcCtD
Rosiglitazone—Dizziness—Dexamethasone—hematologic cancer	3.45e-05	0.000171	CcSEcCtD
Rosiglitazone—Dizziness—Betamethasone—hematologic cancer	3.45e-05	0.000171	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—hematologic cancer	3.43e-05	0.00017	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—hematologic cancer	3.43e-05	0.00017	CcSEcCtD
Rosiglitazone—Nausea—Triamcinolone—hematologic cancer	3.42e-05	0.00017	CcSEcCtD
Rosiglitazone—Rash—Dexamethasone—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Rash—Betamethasone—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Dermatitis—Dexamethasone—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Dermatitis—Betamethasone—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.28e-05	0.000163	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—hematologic cancer	3.28e-05	0.000163	CcSEcCtD
Rosiglitazone—Headache—Dexamethasone—hematologic cancer	3.27e-05	0.000162	CcSEcCtD
Rosiglitazone—Headache—Betamethasone—hematologic cancer	3.27e-05	0.000162	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—hematologic cancer	3.27e-05	0.000162	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—hematologic cancer	3.26e-05	0.000162	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.24e-05	0.000161	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—hematologic cancer	3.23e-05	0.00016	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—hematologic cancer	3.22e-05	0.00016	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—hematologic cancer	3.22e-05	0.00016	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—hematologic cancer	3.11e-05	0.000154	CcSEcCtD
Rosiglitazone—Nausea—Dexamethasone—hematologic cancer	3.1e-05	0.000154	CcSEcCtD
Rosiglitazone—Nausea—Betamethasone—hematologic cancer	3.1e-05	0.000154	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.07e-05	0.000152	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—hematologic cancer	3.07e-05	0.000152	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—hematologic cancer	3.04e-05	0.000151	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—hematologic cancer	3.02e-05	0.00015	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—hematologic cancer	3.01e-05	0.000149	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3e-05	0.000149	CcSEcCtD
Rosiglitazone—Rash—Prednisone—hematologic cancer	2.87e-05	0.000142	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—hematologic cancer	2.86e-05	0.000142	CcSEcCtD
Rosiglitazone—Headache—Prednisone—hematologic cancer	2.85e-05	0.000141	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.84e-05	0.000141	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—hematologic cancer	2.84e-05	0.000141	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—hematologic cancer	2.83e-05	0.00014	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—hematologic cancer	2.81e-05	0.00014	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—hematologic cancer	2.73e-05	0.000135	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—hematologic cancer	2.7e-05	0.000134	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—hematologic cancer	2.69e-05	0.000133	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—hematologic cancer	2.61e-05	0.00013	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—hematologic cancer	2.6e-05	0.000129	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—hematologic cancer	2.55e-05	0.000127	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—hematologic cancer	2.52e-05	0.000125	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—hematologic cancer	2.51e-05	0.000125	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—hematologic cancer	2.43e-05	0.000121	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—hematologic cancer	2.4e-05	0.000119	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—hematologic cancer	2.39e-05	0.000119	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—hematologic cancer	2.38e-05	0.000118	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—hematologic cancer	2.36e-05	0.000117	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—hematologic cancer	2.35e-05	0.000117	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—hematologic cancer	2.33e-05	0.000116	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—hematologic cancer	2.26e-05	0.000112	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—hematologic cancer	2.25e-05	0.000112	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—hematologic cancer	2.24e-05	0.000111	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—hematologic cancer	2.24e-05	0.000111	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—hematologic cancer	2.23e-05	0.000111	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—hematologic cancer	2.18e-05	0.000108	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—hematologic cancer	2.11e-05	0.000105	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—hematologic cancer	2.08e-05	0.000103	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—hematologic cancer	2.07e-05	0.000103	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—hematologic cancer	2.06e-05	0.000102	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—hematologic cancer	1.95e-05	9.7e-05	CcSEcCtD
Rosiglitazone—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.51e-06	6.37e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.49e-06	6.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.45e-06	6.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO2—hematologic cancer	5.44e-06	6.3e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CD—hematologic cancer	5.43e-06	6.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NUP98—hematologic cancer	5.4e-06	6.26e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—IDH1—hematologic cancer	5.36e-06	6.21e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—hematologic cancer	5.36e-06	6.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NUP98—hematologic cancer	5.36e-06	6.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.3e-06	6.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TXN—hematologic cancer	5.3e-06	6.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.3e-06	6.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.28e-06	6.11e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CB—hematologic cancer	5.26e-06	6.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.25e-06	6.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.25e-06	6.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.21e-06	6.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NUP214—hematologic cancer	5.21e-06	6.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.2e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.2e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.2e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.19e-06	6.01e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.18e-06	6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NUP214—hematologic cancer	5.16e-06	5.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SDC1—hematologic cancer	5.16e-06	5.97e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTHFR—hematologic cancer	5.15e-06	5.97e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3R1—hematologic cancer	5.13e-06	5.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.11e-06	5.92e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.11e-06	5.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTR—hematologic cancer	5.1e-06	5.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.1e-06	5.91e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.08e-06	5.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTR—hematologic cancer	5.06e-06	5.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.06e-06	5.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO2—hematologic cancer	5.01e-06	5.8e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.99e-06	5.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO2—hematologic cancer	4.96e-06	5.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.93e-06	5.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NQO1—hematologic cancer	4.91e-06	5.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD44—hematologic cancer	4.91e-06	5.69e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD44—hematologic cancer	4.89e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NQO1—hematologic cancer	4.89e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.87e-06	5.64e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	4.87e-06	5.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.86e-06	5.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.85e-06	5.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.85e-06	5.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.85e-06	5.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—hematologic cancer	4.83e-06	5.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.81e-06	5.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.81e-06	5.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.78e-06	5.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SDC1—hematologic cancer	4.75e-06	5.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.74e-06	5.49e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—hematologic cancer	4.74e-06	5.48e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.73e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SDC1—hematologic cancer	4.7e-06	5.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.65e-06	5.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYCS—hematologic cancer	4.65e-06	5.38e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYCS—hematologic cancer	4.62e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.62e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HSP90AA1—hematologic cancer	4.59e-06	5.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NUP98—hematologic cancer	4.58e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.54e-06	5.26e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CREBBP—hematologic cancer	4.51e-06	5.23e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—hematologic cancer	4.5e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.49e-06	5.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.44e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.44e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.44e-06	5.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NUP214—hematologic cancer	4.41e-06	5.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD44—hematologic cancer	4.39e-06	5.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NQO1—hematologic cancer	4.39e-06	5.08e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—hematologic cancer	4.37e-06	5.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.37e-06	5.06e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EP300—hematologic cancer	4.33e-06	5.01e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.33e-06	5.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.32e-06	5.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTR—hematologic cancer	4.32e-06	5.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.3e-06	4.97e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	4.28e-06	4.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.24e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO2—hematologic cancer	4.24e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—hematologic cancer	4.22e-06	4.89e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—hematologic cancer	4.21e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYCS—hematologic cancer	4.15e-06	4.81e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.13e-06	4.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.12e-06	4.78e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.11e-06	4.76e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—hematologic cancer	4.1e-06	4.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.1e-06	4.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—hematologic cancer	4.09e-06	4.74e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—hematologic cancer	4.09e-06	4.74e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—hematologic cancer	4.08e-06	4.72e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—hematologic cancer	4.05e-06	4.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.05e-06	4.69e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.04e-06	4.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD44—hematologic cancer	4.03e-06	4.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NQO1—hematologic cancer	4.03e-06	4.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDC1—hematologic cancer	4.02e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CREBBP—hematologic cancer	4.01e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NQO1—hematologic cancer	4e-06	4.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD44—hematologic cancer	4e-06	4.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-06	4.59e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.94e-06	4.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.92e-06	4.53e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—EP300—hematologic cancer	3.9e-06	4.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—hematologic cancer	3.88e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.88e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—hematologic cancer	3.86e-06	4.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.84e-06	4.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYCS—hematologic cancer	3.82e-06	4.42e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.81e-06	4.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.8e-06	4.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.79e-06	4.39e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.79e-06	4.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYCS—hematologic cancer	3.78e-06	4.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.77e-06	4.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.77e-06	4.36e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—hematologic cancer	3.77e-06	4.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.76e-06	4.35e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—hematologic cancer	3.76e-06	4.35e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—hematologic cancer	3.75e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NCOR1—hematologic cancer	3.75e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.73e-06	4.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.71e-06	4.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.66e-06	4.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.63e-06	4.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.6e-06	4.17e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.59e-06	4.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—hematologic cancer	3.55e-06	4.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.54e-06	4.1e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—hematologic cancer	3.49e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.46e-06	4.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD44—hematologic cancer	3.42e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NQO1—hematologic cancer	3.42e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.4e-06	3.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.38e-06	3.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.37e-06	3.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.36e-06	3.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.36e-06	3.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.35e-06	3.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.34e-06	3.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.33e-06	3.85e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.32e-06	3.84e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—hematologic cancer	3.31e-06	3.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYCS—hematologic cancer	3.23e-06	3.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.23e-06	3.74e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.22e-06	3.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.21e-06	3.72e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—hematologic cancer	3.2e-06	3.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.19e-06	3.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.16e-06	3.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.14e-06	3.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—hematologic cancer	3.1e-06	3.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.09e-06	3.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.09e-06	3.58e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—EP300—hematologic cancer	3.07e-06	3.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.07e-06	3.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.07e-06	3.55e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—hematologic cancer	3.03e-06	3.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.97e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—hematologic cancer	2.96e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.93e-06	3.4e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.92e-06	3.38e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.89e-06	3.35e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—hematologic cancer	2.89e-06	3.34e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—hematologic cancer	2.87e-06	3.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.85e-06	3.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.8e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—hematologic cancer	2.78e-06	3.22e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—EP300—hematologic cancer	2.73e-06	3.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.73e-06	3.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—hematologic cancer	2.71e-06	3.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.71e-06	3.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.7e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.62e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.62e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.62e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—hematologic cancer	2.62e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.59e-06	3e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—EP300—hematologic cancer	2.59e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CREBBP—hematologic cancer	2.58e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.5e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.46e-06	2.85e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—hematologic cancer	2.44e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—hematologic cancer	2.43e-06	2.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.39e-06	2.76e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—hematologic cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.32e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.31e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3R1—hematologic cancer	2.31e-06	2.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.3e-06	2.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.27e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.19e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—hematologic cancer	2.17e-06	2.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—hematologic cancer	2.13e-06	2.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.13e-06	2.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.11e-06	2.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.07e-06	2.4e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.02e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.02e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—hematologic cancer	1.99e-06	2.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—hematologic cancer	1.98e-06	2.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.95e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.89e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.86e-06	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—hematologic cancer	1.84e-06	2.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.8e-06	2.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—EP300—hematologic cancer	1.77e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.76e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—EP300—hematologic cancer	1.76e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.74e-06	2.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.71e-06	1.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—hematologic cancer	1.69e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—hematologic cancer	1.65e-06	1.91e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—hematologic cancer	1.65e-06	1.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.61e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—EP300—hematologic cancer	1.58e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—hematologic cancer	1.56e-06	1.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.52e-06	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.51e-06	1.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.49e-06	1.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—EP300—hematologic cancer	1.45e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—EP300—hematologic cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.31e-06	1.51e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—hematologic cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—hematologic cancer	1.29e-06	1.49e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—EP300—hematologic cancer	1.23e-06	1.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.23e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—hematologic cancer	1.06e-06	1.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—hematologic cancer	9.53e-07	1.1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.09e-07	1.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—hematologic cancer	8.76e-07	1.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—hematologic cancer	8.69e-07	1.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—hematologic cancer	7.42e-07	8.59e-06	CbGpPWpGaD
